Nov. 18, 2020: Local 4 assignment editor shares experience with COVID-19 vaccine trialLocal 4 assignment editor Matt Triplett said he wanted to do everything he could to help end the pandemic and get us back to a more normal life. “I talked to several people I trust and this is just the right thing to do.”AdWhile most of the world has watched and waited for a vaccine, Triplett decided to help make it happen. After researching various trials, he signed up for a Pfizer vaccine study without hesitation. AdOn Feb. 3, he received his second dose of the Pfizer vaccine. “If you get your chance, please go get the vaccine,” Triplett said.

DETROIT – The FDA’s vaccine advisory committee spoke at length about the ethics of what should happen to those that took the placebo in Pfizer’s vaccine trial. RELATED: Michigan plans for COVID-19 vaccine: What to expect nextShould they now be permitted to get the actual vaccine? Local 4 assignment editor Matt Triplett said he’s ecstatic that Pfizer’s vaccine will soon be available for the first groups of high-priority Americans. Essentially, everyone in the trial is vaccinated again with those who got the placebo the first time getting the vaccine and vice-versa. It doesn’t just impact Pfizer’s trial.

DETROIT – Pfizer announced on Wednesday that it is ready to submit its COVID-19 vaccine to the Food and Drug Administration (FDA) for review. The drugmaker reported that its final analysis finds the vaccine is 95 percent effective. READ: Pfizer: COVID-19 shot 95% effective, seeking clearance soonLocal 4 assignment editor Matt Triplett said he wanted to do everything he could to help end the pandemic and get us back to a more normal life. “I talked to several people I trust and this is just the right thing to do.”While most of the world has watched and waited for a vaccine, Triplett decided to help make it happen. Triplett still doesn’t know if he received the actual vaccine or a placebo.